PressFebruary 2, 2022 Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001
PressFebruary 1, 2022 PharmaDrug Announces Filing of US Provisional Patent for Cepharanthine to Treat Prostate Cancer
PressJanuary 31, 2022 Filament Health Subsidiary Psilo Scientific Announces Inclusion in Health Canada List of Licensed Psilocybin Producers
PressJanuary 29, 2022 atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments
PressJanuary 29, 2022 Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions
PressJanuary 25, 2022 Mindset Pharma Enters Manufacturing Agreement to Produce Next-Generation Psilocybin Drug Candidate, MSP-1014
PressJanuary 21, 2022 Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp.
PressJanuary 20, 2022 BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder Treatment
PressJanuary 19, 2022 Nucleus, a Data-Driven Psychedelics Platform, Begins to Orbit the Mental Health Crisis; Logan Lenz to Captain the Ship
PressJanuary 19, 2022 Survey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address Anxiety, Depression and PTSD
PressJanuary 14, 2022 MYND Life Sciences Announces Collaborative Research Agreement with the University of British Columbia
PressJanuary 13, 2022 Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients
PressJanuary 12, 2022 atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program
PressJanuary 7, 2022 Australian Government pledges to donate $14.8 Million for Psychedelic Medicine Research
PressJanuary 7, 2022 Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
PressJanuary 5, 2022 Red Light Holland Expands iMicrodose Branded Product Offerings and Launches the Sale of All-in-One Mushroom Fruiting Extracts; Capsules and Tinctures
PressJanuary 3, 2022 Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights
PressDecember 29, 2021 Mindset Pharma Announces Filing of International Patent Application Covering its Family 3 “Microdose” Compounds
